{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:23:11Z","timestamp":1760080991148},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,29]]},"DOI":"10.7759\/cureus.70462","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T02:38:31Z","timestamp":1727663911000},"source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Thyroid Function Tests Among Type 2 Diabetes Patients With and Without Diabetic Nephropathy and Controls"],"prefix":"10.7759","author":[{"given":"J. T. V. Krishna","family":"Pavan Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma M","family":"A","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects","volume":"83","author":"Tiwari AK","year":"2022","unstructured":"Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci. 2022, 83:30-8.","journal-title":"Curr Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.15.3.143","article-title":"Thyroid disease and diabetes","volume":"15","author":"Wu P","year":"2022","unstructured":"Wu P. Thyroid disease and diabetes. Diabetes Spectr. 2022, 15:143. 10.2337\/diaspect.15.3.143","journal-title":"Diabetes Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4021%2Fjocmr2010.03.281w","article-title":"Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic","volume":"75","author":"Papazafiropoulou A","year":"2010","unstructured":"Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kardara M, Stamataki P, Pappas S. Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic. J Clin Med Res. 2010, 75:10. 10.4021%2Fjocmr2010.03.281w","journal-title":"J Clin Med Res"},{"key":"ref4","article-title":"Frequency of thyroid dysfunction among diabetes in Punjabi population","author":"Singh G","year":"2011","unstructured":"Singh G, Gupta V, Sharma AK, Gupta N. Frequency of thyroid dysfunction among diabetes in Punjabi population. Biol Forum Int J. 2011,","journal-title":"Biol Forum Int J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02270.x","article-title":"Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients","volume":"24","author":"Chen HS","year":"2007","unstructured":"Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, Lin HD. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med. 2007, 24:1336-44. 10.1111\/j.1464-5491.2007.02270.x","journal-title":"Diabet Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0298","article-title":"Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study","volume":"90","author":"Chubb SA","year":"2005","unstructured":"Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab. 2005, 90:5317-20. 10.1210\/jc.2005-0298","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02376.x","article-title":"Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies","volume":"64","author":"Kadiyala R","year":"2010","unstructured":"Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract. 2010, 64:1130-9. 10.1111\/j.1742-1241.2010.02376.x","journal-title":"Int J Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez JF","year":"2011","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Muros de Fuentes M, Garc\u00eda-P\u00e9rez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011, 7:327-40. 10.1038\/nrneph.2011.51","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris GJ","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000, 160:526-34. 10.1001\/archinte.160.4.526","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell JG","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87:489-99. 10.1210\/jcem.87.2.8182","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","article-title":"Frequency of thyroid dysfunction in diabetic patients: value of annual screening","volume":"12","author":"Perros P","year":"1995","unstructured":"Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995, 12:622-7. 10.1111\/j.1464-5491.1995.tb00553.x","journal-title":"Diabet Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1181","article-title":"Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study","volume":"26","author":"Umpierrez GE","year":"2003","unstructured":"Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, Kitabchi AE. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003, 26:1181-5. 10.2337\/diacare.26.4.1181","journal-title":"Diabetes Care"},{"key":"ref13","article-title":"Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan","volume":"25","author":"Radaideh AR","year":"2004","unstructured":"Radaideh AR, Nusier MK, Amari FL, Bateiha AE, El-Khateeb MS, Naser AS, Ajlouni KM. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J. 2004, 25:1046-50.","journal-title":"Saudi Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives","volume":"8","author":"Chen L","year":"2011","unstructured":"Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011, 8:228-36. 10.1038\/nrendo.2011.183","journal-title":"Nat Rev Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/204893","article-title":"Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes","volume":"2015","author":"Wu J","year":"2015","unstructured":"Wu J, Li X, Tao Y, Wang Y, Peng Y. Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes. Int J Endocrinol. 2015, 2015:204893. 10.1155\/2015\/204893","journal-title":"Int J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","unstructured":"Diagnosis and classification of diabetes. standards of care in diabetes-2024. Diabetes Care. 2024, 47:S20-42. 10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross JL","year":"2005","unstructured":"Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005, 28:164-76. 10.2337\/diacare.28.1.164","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9507028","article-title":"Thyroid function in patients with type 2 diabetes mellitus and diabetic nephropathy: a single center study","volume":"2018","author":"Zhao W","year":"2018","unstructured":"Zhao W, Li X, Liu X, Lu L, Gao Z. Thyroid function in patients with type 2 diabetes mellitus and diabetic nephropathy: a single center study. J Thyroid Res. 2018, 2018:9507028. 10.1155\/2018\/9507028","journal-title":"J Thyroid Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-69","article-title":"The relationship between obesity and diabetic nephropathy in China","volume":"14","author":"Chen HM","year":"2013","unstructured":"Chen HM, Shen WW, Ge YC, Zhang YD, Xie HL, Liu ZH. The relationship between obesity and diabetic nephropathy in China. BMC Nephrol. 2013, 14:69. 10.1186\/1471-2369-14-69","journal-title":"BMC Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/JOD.JOD_17_19","article-title":"A study on prevalence and risk factors of diabetic nephropathy in newly detected type 2 diabetic patients","volume":"11","author":"Ravindran R","year":"2020","unstructured":"Ravindran R, Kalaivalli S, Srinivasagalu S, Karthik L. A study on prevalence and risk factors of diabetic nephropathy in newly detected type 2 diabetic patients. J Diabetol. 2020, 11:10.4103\/JOD.JOD_17_19","journal-title":"J Diabetol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm TV","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022, 55:31-55. 10.1016\/j.immuni.2021.12.013","journal-title":"Immunity"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu14071457","article-title":"Pro-inflammatory profile of adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease","volume":"14","author":"Czaja-Stolc S","year":"2022","unstructured":"Czaja-Stolc S, Potrykus M, Stankiewicz M, Kaska \u0141, Ma\u0142gorzewicz S. Pro-inflammatory profile of adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease. Nutrients. 2022, 14:10.3390\/nu14071457","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.19","article-title":"Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy","volume":"77","author":"Middleton JP","year":"2010","unstructured":"Middleton JP, Pun PH. Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. Kidney Int. 2010, 77:753-5. 10.1038\/ki.2010.19","journal-title":"Kidney Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh D","year":"2019","unstructured":"Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019, 79:365-79. 10.1007\/s40265-019-1064-1","journal-title":"Drugs"},{"key":"ref25","article-title":"Study of pulmonary function tests in diabetic nephropathy","volume":"70","author":"Chintalapati A","year":"2022","unstructured":"Chintalapati A, Babu S, Cs C. Study of pulmonary function tests in diabetic nephropathy. J Assoc Physicians India. 2022, 70:11-2.","journal-title":"J Assoc Physicians India"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01393-4","article-title":"Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study","volume":"23","author":"Iwakura H","year":"2023","unstructured":"Iwakura H, Takagi T, Inaba H, et al.. Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study. BMC Endocr Disord. 2023, 23:146. 10.1186\/s12902-023-01393-4","journal-title":"BMC Endocr Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01299-1","article-title":"Association between thyroid hormones and diabetic kidney disease in Chinese adults","volume":"23","author":"Liu MC","year":"2023","unstructured":"Liu MC, Li JL, Wang YF, et al.. Association between thyroid hormones and diabetic kidney disease in Chinese adults. BMC Endocr Disord. 2023, 23:56. 10.1186\/s12902-023-01299-1","journal-title":"BMC Endocr Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22904-7","article-title":"Association between thyroid hormone levels and diabetic kidney disease in euthyroid patients with type 2 diabetes","volume":"8","author":"Zou J","year":"2018","unstructured":"Zou J, Tian F, Zhang Y, et al.. Association between thyroid hormone levels and diabetic kidney disease in euthyroid patients with type 2 diabetes. Sci Rep. 2018, 8:4728. 10.1038\/s41598-018-22904-7","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.176144","article-title":"Identification of urinary proteins potentially associated with diabetic kidney disease","volume":"26","author":"Marikanty RK","year":"2016","unstructured":"Marikanty RK, Gupta MK, Cherukuvada SV, et al.. Identification of urinary proteins potentially associated with diabetic kidney disease. Indian J Nephrol. 2016, 26:434-45. 10.4103\/0971-4065.176144","journal-title":"Indian J Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4626125","article-title":"Urinary biomarkers in the assessment of early diabetic nephropathy","volume":"2016","author":"Gluhovschi C","year":"2016","unstructured":"Gluhovschi C, Gluhovschi G, Petrica L, et al.. Urinary biomarkers in the assessment of early diabetic nephropathy. J Diabetes Res. 2016, 2016:4626125. 10.1155\/2016\/4626125","journal-title":"J Diabetes Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294771-comparison-of-thyroid-function-tests-among-type-2-diabetes-patients-with-and-without-diabetic-nephropathy-and-controls","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T02:38:33Z","timestamp":1727663913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294771-comparison-of-thyroid-function-tests-among-type-2-diabetes-patients-with-and-without-diabetic-nephropathy-and-controls"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.70462","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,29]]}}}